Authorized purpose: QOCA image Smart CXR analyzes adult chest X-ray images and flags cases with suspected pneumothorax to support prioritization for radiologist review.
Clinical role
Passive case-level triage notification within the radiologist worklist; no cases are removed from the standard workflow.
Images and patients
X-ray/Radiography · Chest/Lung
Key limitation
Keep in mind: The output is not a substitute for radiologist diagnosis and is not for standalone clinical decision-making. It is limited to PA or AP erect adult chest radiographs and does not directly indicate image locations or anomalies.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: QOCA image Smart CXR analyzes adult chest X-ray images and flags cases with suspected pneumothorax to support prioritization for radiologist review.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest/Lung Input: Adult chest radiographs in PA or AP erect view, received as DICOM files pushed from PACS.
Who uses it?Intended users: Radiologists reviewing adult chest radiographs.
What does the software produce?Output: A notation beside cases with suspected pneumothorax for radiologist prioritization; it does not directly mark the image location or anomaly.
What is its most important limitation?Key limitation: The output is not a substitute for radiologist diagnosis and is not for standalone clinical decision-making. It is limited to PA or AP erect adult chest radiographs and does not directly indicate image locations or anomalies.
Clinical takeaway. Clinical role: QOCA image Smart CXR analyzes adult chest X-ray images and flags cases with suspected pneumothorax to support prioritization for radiologist review.
Evidence takeaway. Evidence from the reviewed source record: The performance of the subject device, QOCA® image Smart CXR Image Processing System, has been validated in two separate pivotal studies. The performance of the subject device across the performance assessment dataset achieves an area under the curve (AUC) of 97.8% (95% CI: [97.0%, 98.5%]); in addition, the sensitivity and specificity achieves 92.5% (95% CI: [90.5%, 94.2%]), 94.0% (95% CI: [93.9%, 94.6%]) respectively, without subgroup breakdown.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
QOCA image Smart CXR analyzes adult chest X-ray images and flags cases with suspected pneumothorax to support prioritization for radiologist review.
Exact FDA submission
Checked 2026-09-19
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
The output is not a substitute for radiologist diagnosis and is not for standalone clinical decision-making. It is limited to PA or AP erect adult chest radiographs and does not directly indicate image locations or anomalies.
Exact FDA submission
Checked 2026-09-19
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
The performance of the subject device, QOCA® image Smart CXR Image Processing System, has been validated in two separate pivotal studies. The performance of the subject device across the performance assessment dataset achieves an area under the curve (AUC) of 97.8% (95% CI: [97.0%, 98.5%]); in addition, the sensitivity and specificity achieves 92.5% (95% CI: [90.5%, 94.2%]), 94.0% (95% CI: [93.9%, 94.6%]) respectively, without subgroup breakdown.
Exact FDA submission
Checked 2026-09-19
The replacement uses the packet's pivotal-study and aggregate performance results without adding an independent-outcome characterization.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The performance of the subject device, QOCA® image Smart CXR Image Processing System, has been validated in two separate pivotal studies. The performance of the subject device across the performance assessment dataset achieves an area under the curve (AUC) of 97.8% (95% CI: [97.0%, 98.5%]); in addition, the sensitivity and specificity achieves 92.5% (95% CI: [90.5%, 94.2%]), 94.0% (95% CI: [93.9%, 94.6%]) respectively, without subgroup breakdown.
FDA source
Exact FDA submission
Checked 2026-09-19
The replacement uses the packet's pivotal-study and aggregate performance results without adding an independent-outcome characterization.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
QOCA image Smart CXR Image Processing System regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K221868
Samplen=6052
IndependenceIndependence not established
K221868
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Adult chest radiographs in PA or AP erect view, received as DICOM files pushed from PACS.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The device connects with hospital PACS, analyzes DICOM files pushed from PACS, and presents case-level notations in its viewer. Exact local interface compatibility requires site validation.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes QOCA image Smart CXR as a web-based medical device that provides case sorting and image viewing and supports multiple users at a time. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "QOCA® image Smart CXR Image Processing System, is a web-based medical device using a locked artificial intelligence algorithm." … "provides features such as cases sorting and image viewing, and supports multiple users at a time.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: A notation beside cases with suspected pneumothorax for radiologist prioritization; it does not directly mark the image location or anomaly.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: A notation beside cases with suspected pneumothorax for radiologist prioritization; it does not directly mark the image location or anomaly.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes QOCA image Smart CXR as a web-based medical device that provides case sorting and image viewing and supports multiple users at a time. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "QOCA® image Smart CXR Image Processing System, is a web-based medical device using a locked artificial intelligence algorithm." … "provides features such as cases sorting and image viewing, and supports multiple users at a time.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
The device connects with hospital PACS, analyzes DICOM files pushed from PACS, and presents case-level notations in its viewer. Exact local interface compatibility requires site validation.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
28Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-14 - Exact FDA submission
No current exact-product price, contract term, or implementation fee was established.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-14 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-14 - Exact FDA submission
Current security controls, data retention, access model, and assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-14 - Exact FDA submission
Current training, competency, and support commitments require vendor confirmation.
Monitoring: Not verified - checked 2026-09-14 - Exact FDA submission
Site-specific quality monitoring, update control, escalation, and incident-response commitments require vendor and local governance evidence.
Authorized purpose: Passive study-level worklist triage for suspected pneumothorax and/or pleural effusion on adult PA or AP chest X-rays; it is not a proactive specialist alert.
Authorized purpose: Passive triage of adult AP chest radiographs for an endotracheal-tube tip more than 7 cm above the carina, less than 3 cm above the carina, below the carina in the right or left mainstem, or other listed malposition states.
Authorized purpose: Passive worklist prioritization for suspected pleural effusion and/or pneumothorax on frontal PA or AP chest radiographs in transitional adolescents aged 18-21 and adults aged 22 years and older; not diagnostic or a rule-out function.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.